Major adverse cardiovascular events following partial nephrectomy: a procedure-specific risk index.

IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY Therapeutic Advances in Urology Pub Date : 2022-03-18 eCollection Date: 2022-01-01 DOI:10.1177/17562872221084847
Ali A Nasrallah, Habib A Dakik, Nassib F Abou Heidar, Jad A Najdi, Oussama G Nasrallah, Mazen Mansour, Hani Tamim, Albert El Hajj
{"title":"Major adverse cardiovascular events following partial nephrectomy: a procedure-specific risk index.","authors":"Ali A Nasrallah,&nbsp;Habib A Dakik,&nbsp;Nassib F Abou Heidar,&nbsp;Jad A Najdi,&nbsp;Oussama G Nasrallah,&nbsp;Mazen Mansour,&nbsp;Hani Tamim,&nbsp;Albert El Hajj","doi":"10.1177/17562872221084847","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Partial nephrectomy (PN) is associated with a non-negligible risk of postoperative cardiovascular morbidity and mortality. Identification of high-risk patients may enable optimization of perioperative management and consideration of alternative approaches. The authors aim to develop a procedure-specific cardiovascular risk index for PN patients and compare its performance to the widely used revised cardiac risk index (RCRI) and AUB-HAS2 cardiovascular risk index.</p><p><strong>Methods: </strong>The cohort was derived from the American College of Surgeons - National Surgical Quality Improvement Program (ACS-NSQIP) database. The primary outcome was the incidence of major adverse cardiovascular events (MACE), defined as 30-day postoperative incidence of myocardial infarction, stroke, or mortality. A multivariate logistic regression model was constructed; performance and calibration were evaluated using an ROC analysis and the Hosmer-Lemeshow test and compared to the RCRI and the AUB-HAS2 index.</p><p><strong>Results: </strong>In a cohort of 4795 patients, MACE occurred in 52 (1.1%) patients. A univariate analysis yielded 13 eligible variables for entry into the multivariate model. The final PN-A<sub>4</sub>CH model utilized six variables: <b>A</b>ge ⩾75 years, <b>A</b>SA class >2, <b>A</b>nemia, surgical <b>A</b>pproach, <b>C</b>reatinine >1.5, and history of <b>H</b>eart disease. Index ROC analysis provided a C-statistic of 0.81, calibration <i>R</i> <sup>2</sup> was 0.99, and sensitivity was 85%. In comparison, the RCRI and AUB-HAS2 C-statistics were 0.59 and 0.68, respectively.</p><p><strong>Conclusion: </strong>This study proposes a novel procedure-specific cardiovascular risk index. The PN-A<sub>4</sub>CH index demonstrated good predictive ability and excellent calibration using a large national database and may enable further individualization of patient care and optimization of patient selection.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2022-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/bf/10.1177_17562872221084847.PMC8935558.pdf","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562872221084847","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 6

Abstract

Introduction: Partial nephrectomy (PN) is associated with a non-negligible risk of postoperative cardiovascular morbidity and mortality. Identification of high-risk patients may enable optimization of perioperative management and consideration of alternative approaches. The authors aim to develop a procedure-specific cardiovascular risk index for PN patients and compare its performance to the widely used revised cardiac risk index (RCRI) and AUB-HAS2 cardiovascular risk index.

Methods: The cohort was derived from the American College of Surgeons - National Surgical Quality Improvement Program (ACS-NSQIP) database. The primary outcome was the incidence of major adverse cardiovascular events (MACE), defined as 30-day postoperative incidence of myocardial infarction, stroke, or mortality. A multivariate logistic regression model was constructed; performance and calibration were evaluated using an ROC analysis and the Hosmer-Lemeshow test and compared to the RCRI and the AUB-HAS2 index.

Results: In a cohort of 4795 patients, MACE occurred in 52 (1.1%) patients. A univariate analysis yielded 13 eligible variables for entry into the multivariate model. The final PN-A4CH model utilized six variables: Age ⩾75 years, ASA class >2, Anemia, surgical Approach, Creatinine >1.5, and history of Heart disease. Index ROC analysis provided a C-statistic of 0.81, calibration R 2 was 0.99, and sensitivity was 85%. In comparison, the RCRI and AUB-HAS2 C-statistics were 0.59 and 0.68, respectively.

Conclusion: This study proposes a novel procedure-specific cardiovascular risk index. The PN-A4CH index demonstrated good predictive ability and excellent calibration using a large national database and may enable further individualization of patient care and optimization of patient selection.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肾部分切除术后的主要不良心血管事件:一个特定手术的风险指数。
部分肾切除术(PN)与术后心血管疾病和死亡率的不可忽视的风险相关。高危患者的识别可以优化围手术期管理和考虑替代方法。作者的目的是为PN患者制定一个特定手术的心血管风险指数,并将其与广泛使用的修订心脏风险指数(RCRI)和AUB-HAS2心血管风险指数进行比较。方法:该队列来自美国外科医师学会-国家手术质量改进计划(ACS-NSQIP)数据库。主要终点是主要不良心血管事件(MACE)的发生率,定义为术后30天心肌梗死、卒中或死亡率的发生率。建立多元logistic回归模型;使用ROC分析和Hosmer-Lemeshow检验对其性能和校准进行评估,并与RCRI和AUB-HAS2指数进行比较。结果:在4795例患者队列中,52例(1.1%)患者发生MACE。单变量分析产生了13个可进入多变量模型的合格变量。最终的PN-A4CH模型利用了六个变量:年龄大于或等于75岁,ASA类别>2,贫血,手术入路,肌酐>1.5,和心脏病史。指标ROC分析的c统计量为0.81,校正r2为0.99,灵敏度为85%。相比之下,RCRI和AUB-HAS2 c统计量分别为0.59和0.68。结论:本研究提出了一种新的手术特异性心血管危险指数。PN-A4CH指数在大型国家数据库中显示出良好的预测能力和出色的校准能力,可以进一步实现患者护理的个性化和患者选择的优化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
39
审稿时长
10 weeks
期刊介绍: Therapeutic Advances in Urology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of urology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in urology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest across all areas of urology, including treatment of urological disorders, with a focus on emerging pharmacological therapies.
期刊最新文献
Clinical use of nadofaragene firadenovec-vncg Effect of surgical, medical, and behavioral weight loss on hormonal and sexual function in men: a contemporary narrative review Proceedings from the Second International Urology Cancer Summit, 27th September, Portsmouth, UK PARP inhibitors alone or in combination for prostate cancer. Comparison of ureteoroscopy and laser stone fragmentation between Holmium: YAG laser with MOSES versus non-MOSES technology: a prospective single-center propensity score-matched analysis using similar laser settings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1